Masimo Hit With IP Suit Over Blood-Testing Technology
An early-stage medical research company hit Masimo Corp. with a lawsuit Wednesday in California federal court alleging that Masimo infringed three of its patents through its development and sale of noninvasive...To view the full article, register now.
Already a subscriber? Click here to view full article